Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by Hanover Media Strategy Limited naming Billy Kelleher .
Filed returns
21
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| Sep–Dec 2025 | Hanover Media Strategy Limited | Transport | A site tour of Enterprise's Cork branch. (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2025 | Hanover Media Strategy Limited | Transport | Invitation for site tour of Enterprise's airport branch (Public policy or programme) | 7 | On lobbying.ie |
| Sep–Dec 2024 | Hanover Media Strategy Limited | Health | Meeting request to discuss the competitiveness of the pharmaceutical sector (Public policy or programme) | 5 | On lobbying.ie |
| Sep–Dec 2024 | Hanover Media Strategy Limited | Transport | Introductory meeting (Public policy or programme) | 3 | On lobbying.ie |
| Sep–Dec 2023 | Hanover Media Strategy Limited | Health | EU Pharmaceutical Regulation (Legislation) | 1 | On lobbying.ie |
| Sep–Dec 2023 | Hanover Media Strategy Limited | Health | Site tour of Bray manufacturing site and discussion on EU pharmaceutical policy. (Legislation) | 1 | On lobbying.ie |
| May–Aug 2023 | Hanover Media Strategy Limited | Health | EU regulation on substances of human origin & revision of EU Pharmaceutical Regulation (Legislation) | 1 | On lobbying.ie |
| Jan–Apr 2023 | Hanover Media Strategy Limited | Health | Pharmaceutical innovation in the EU and the revision of EU pharmaceutical legislation. (Public policy or programme) | 5 | On lobbying.ie |
| Jan–Apr 2023 | Hanover Media Strategy Limited | Health | EU regulation on substances of human origin (Legislation) | 2 | On lobbying.ie |
| Sep–Dec 2022 | Hanover Media Strategy Limited | Health | Briefing on AstraZeneca's operations in Ireland. (Public policy or programme) | 2 | On lobbying.ie |
| May–Aug 2022 | Hanover Media Strategy Limited | Health | Briefing on AstraZeneca's operations in Ireland. (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2022 | Hanover Media Strategy Limited | Health | Introducing Horizon and its presence in Ireland (Public policy or programme) | 16 | On lobbying.ie |
| Jan–Apr 2019 | Hanover Media Strategy Limited | Finance | Cost of Motor Insurance Policies in Ireland (Legislation) | 27 | On lobbying.ie |
| Sep–Dec 2018 | Hanover Media Strategy Limited | Finance | Cost of Motor Insurance Policies in Ireland (Legislation) | 21 | On lobbying.ie |
| Jan–Apr 2018 | Hanover Media Strategy Limited | Health | Reimbursement of Vimizim for Morquio A Syndrome (Matters involving public funds) | 12 | On lobbying.ie |
| Jan–Apr 2018 | Hanover Media Strategy Limited | Health | Creation of national policy to increase availability of Orphan Medicinal Products (Legislation) | 12 | On lobbying.ie |
| Sep–Dec 2017 | Hanover Media Strategy Limited | Health | Reimbursement of Vimizim for Morquio A Syndome (Matters involving public funds) | 16 | On lobbying.ie |
| Sep–Dec 2017 | Hanover Media Strategy Limited | Health | Reimbursement of Translarna for nonsense mutation Duchenne Muscular Dystrophy (Public policy or programme) | 16 | On lobbying.ie |
| May–Aug 2017 | Hanover Media Strategy Limited | Health | Reimbursement of Translarna for nonsense mutation Duchenne Muscular Dystrophy (Matters involving public funds) | 18 | On lobbying.ie |
| May–Aug 2017 | Hanover Media Strategy Limited | Health | Rare Disease Medicines (Public policy or programme) | 11 | On lobbying.ie |
| Jan–Apr 2017 | Hanover Media Strategy Limited | Health | Reimbursement of Translarna for nonsense mutation Duchenne Muscular Dystrophy (Matters involving public funds) | 19 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 16 | 76.2% | |
| Transport | 3 | 14.3% | |
| Finance | 2 | 9.5% |